Please login to the form below

Not currently logged in
Email:
Password:

Rezolsta

This page shows the latest Rezolsta news and features for those working in and with pharma, biotech and healthcare.

FDA approves BMS’ Evotaz for HIV

FDA approves BMS’ Evotaz for HIV

Cobicistat is already a crucial part of several HIV treatments, including Rezolsta/Prezcobix, which pairs the drug with Janssen's Prezista (darunavir), and Gilead's own combination therapy Stribild.

Latest news

  • EMA backs 15 new medicines for use in EU EMA backs 15 new medicines for use in EU

    Janssen's HIV treatment. Janssen looks set to expand its efforts in HIV treatment with a recommendation for Rezolsta, a combination of the company's Prezista (darunavir) and Gilead's boosting

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics